Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ford Motor Company (F) vs Invesco Ltd. (IVZ) Price & Performance

Ford Motor CompanyTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Ford Motor Company vs Invesco Ltd. — how do they compare? Ford Motor Company trades at $12.28 (market cap $48.85B), while Invesco Ltd. trades at $30.09 (market cap $13.28B). The key difference: Ford Motor Company is far larger — about 3.7× Invesco Ltd.'s market cap, and Ford Motor Company pays the higher dividend (4.9%). Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 104 Days and Invesco Ltd. for 77 Days on average.

FIVZ
Market Cap
$48.85B$13.28B
Volume
57,748,9653,698,033
Sector
Consumer CyclicalFinancials
52-Week High
$17.44$33.31
52-Week Low
$11.21$22.44
Typical Hold Time
104 Days77 Days
Enterprise Value
$180.81B$23.45B
Dividend Yield
4.9%2.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ford Motor Company

Ford Motor Company (F) trades at $12.125, down 1.22% on the day, amid a challenging quarter with a 6.6% sales decline reported for Q3 2026 (Reuters, 2026-10-02). The stock shows a bearish technical signal, with moving averages indicating a downtrend. Fundamentally, the company reported a net loss of $8.18 billion for 2025, with negative profit margins and ROE, though operating cash flow remains strong at $21.28 billion. Recent news highlights supplier disruptions affecting F-150 production and a strategic shift toward hybrids.

The outlook for Ford is mixed, with analyst consensus leaning toward a 'Hold' (48.93% of ratings) and a price target of $15.90 suggesting potential upside. Key opportunities include the growing hybrid segment and strong commercial division, while risks involve ongoing sales volatility, high debt levels, and competitive pressures from Asian automakers. Investors should weigh the company's cash flow strength against profitability challenges and market share losses.

Invesco Ltd.

Invesco (IVZ) trades at $30.50, up 0.39% on the day, with a mixed technical outlook showing bearish moving averages but neutral oscillators. Fundamentally, the company reported a net loss of $281.7 million for 2025 despite revenue growth to $6.38 billion, with profitability metrics like ROE at -2.97% indicating challenges. Recent news highlights the expansion of its QQQ ETF suite and a dividend declaration, while analyst consensus remains cautiously optimistic with a $33.71 price target.

The outlook for IVZ hinges on reversing negative earnings trends and capitalizing on ETF growth initiatives. Key opportunities include strong asset under management growth and product innovation, but risks persist from competitive pressures and market volatility. Investors should weigh the potential for operational improvement against ongoing profitability concerns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

F
100% Buy0% Sell
Avg holding period · 104 Days
IVZ

No sentiment data available yet.

Top news

Latest headlines on both assets

About Ford Motor Company

Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.

Read more on F →

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ →